SARS-CoV-2 vaccination and infection in ozanimod-treated participants with relapsing multiple sclerosis.
Ann Clin Transl Neurol
; 10(10): 1725-1737, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37550942
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Multiple Sclerosis
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Ann Clin Transl Neurol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: